主动脉瓣狭窄需瓣膜置换的前瞻性蛋白质组学生物标志物
在一项大型人群调查中,334例后来因主动脉瓣狭窄(AS)手术的患者与匹配对照的基线血浆用92种心血管候选蛋白检测,发现6种蛋白与AS相关,但亚组分析显示关联主要由合并动脉粥样硬化疾病驱动,验证队列中除IL-17RA外均在合并冠心病患者中重复。
要点
- 6种蛋白与日后因AS手术相关,但关联似乎由合并动脉粥样硬化疾病驱动。
- 无可见冠心病者中仅GDF-15和galectin-4关联支持,且排除近期采血后减弱。
- 验证队列中除IL-17RA外均在合并冠心病AS患者中重复,无冠心病者未重复。
核心结论
- 5种蛋白在AS手术前数年即存在改变,但其关联似乎由合并动脉粥样硬化疾病驱动。
研究设计与样本
- 基于大型人群调查的巢式病例对照研究,发现队列334例日后因AS手术患者,每例匹配2名对照,基线血浆用多重邻位延伸分析检测92种心血管候选蛋白。
- 另设验证队列106例额外病例与212名匹配对照。
主要发现
- 发现队列中6种蛋白(GDF-15、galectin-4、vWF、IL-17RA、TfR1、PCSK9)与病例状态相关,每SD蛋白信号增加的OR为1.25至1.37。
- 校正基线经典心血管危险因素后结果相似。
- 无可见冠心病的病例-对照三联体(n=133)中,GDF-15(OR 1.40,95%CI 1.10-1.78)和galectin-4(OR 1.27,95%CI 1.02-1.59)关联支持,但排除手术前5年内采血者后减弱。
- 合并冠心病三联体(n=201)中,所有6种蛋白在所有敏感性分析中均与病例状态稳健相关。
- 验证研究中,除IL-17RA外,其余蛋白在合并冠心病的AS患者中重复,但在无冠心病AS患者中未重复。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Aortic valve stenosis (AS) is the most common indication for cardiac valve surgery; untreated AS is linked to high mortality. The etiological background of AS is unknown. Previous human studies were typically based on case-control studies. Biomarkers identified in prospective studies could lead to novel mechanistic insights. METHODS: Within a large population survey with blood samples obtained at baseline, 334 patients were identified who later underwent surgery for AS (median age [interquartile range], 59.9 [10.4] years at survey and 68.3 [12.7] at surgery; 48% female). For each case, 2 matched referents were allocated. Plasma was analyzed with the multiplex proximity extension assay for screening of 92 cardiovascular candidate proteins. Conditional logistic regression models were used to assess associations between each protein and AS, with correction for multiple testing. A separate set of 106 additional cases with 212 matched referents was used in a validation study. RESULTS: Six proteins (growth differentiation factor 15, galectin-4, von Willebrand factor, interleukin 17 receptor A, transferrin receptor protein 1, and proprotein convertase subtilisin/kexin type 9) were associated with case status in the discovery cohort; odds ratios ranged from 1.25 to 1.37 per SD increase in the protein signal. Adjusting the multivariable models for classical cardiovascular risk factors at baseline yielded similar results. Subanalyses of case-referent triplets (n=133) who showed no visible coronary artery disease at the time of surgery in the index person supported associations between AS and growth differentiation factor 15 (odds ratio, 1.40; 95% confidence interval, 1.10-1.78) and galectin-4 (odds ratio, 1.27; 95% confidence interval, 1.02-1.59), but these associations were attenuated after excluding individuals who donated blood samples within 5 years before surgery. In triplets (n=201), which included index individuals with concurrent coronary artery disease at the time of surgery, all 6 proteins were robustly associated with case status in all sensitivity analyses. In the validation study, the association of all but 1 (interleukin 17 receptor A) of these proteins were replicated in patients with AS with concurrent coronary artery disease but not in patients with AS without coronary artery disease. CONCLUSIONS: We provide evidence that 5 proteins were altered years before AS surgery and that the associations seem to be driven by concurrent atherosclerotic disease.
引用
- Ljungberg J, Janiec M, Bergdahl IA, et al. Proteomic Biomarkers for Incident Aortic Stenosis Requiring Valvular Replacement. Circulation. 2018. PMID: 29487139. doi:10.1161/CIRCULATIONAHA.117.030414
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。